Viewing StudyNCT00060944



Ignite Creation Date: 2024-05-05 @ 11:30 AM
Last Modification Date: 2024-10-26 @ 9:08 AM
Study NCT ID: NCT00060944
Status: COMPLETED
Last Update Posted: 2014-09-08
First Post: 2003-05-16

Brief Title: A Study to Assess Treatment With 2 Different Dosing Schedules of Trabectidin Administered to Patients With Advanced Cancer
Sponsor: Johnson Johnson Pharmaceutical Research Development LLC
Organization: Johnson Johnson Pharmaceutical Research Development LLC

Key Dates - Follows AllAPIJSON File Order

Start Date: 2003-05
Start Date Type: None
Primary Completion Date: 2008-05
Primary Completion Date Type: ACTUAL
Completion Date: 2008-05
Completion Date Type: ACTUAL
First Submit Date: 2003-05-16
First Submit QC Date: May 16 2003
Study First Post Date: 2003-05-19
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: 2014-09-08
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: 2011-08-12
Disp First Submit QC Date: August 12 2011
Disp First Post Date: 2011-08-15
Disp First Post Date Type: ESTIMATED
Last Update Submit Date: 2014-08-28
Last Update Post Date: 2014-09-08
Last Update Post Date Type: ESTIMATED